Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | 3 | 0 | 1 | 0 | €26.40 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.14 | - | - |
| UCB S.A. | 1 | 0 | 0 | 0 | €154.40 | - | - |
| Fresenius Medical Care AG & Co KGaA ADR | 8 | 1 | 1 | 0 | €17.60 | - | - |
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €32.81 | - | - |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €13.46 | - | - |
| Steris Corp. | 1 | 0 | 0 | 0 | €222.00 | - | - |
| Veeva Systems A | 2 | 0 | 0 | 0 | €177.35 | - | - |
| Koninklijke Philips Electronics ADR | 4 | 1 | 1 | 0 | €25.80 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 17 | 0 | 2 | 0 | €16.25 | €18.95 | 16.612% |
| Dentsply Sirona Inc. | 17 | 0 | 3 | 0 | €25.09 | €35.26 | 40.550% |
| Roche Holding AG ADR | 3 | 3 | 1 | 1 | €37.36 | €38.00 | 1.706% |
| Pfizer Inc. | 29 | 4 | 2 | 0 | €28.45 | €41.49 | 45.843% |
| Bayer AG | 15 | 3 | 2 | 2 | €27.30 | €45.00 | 64.835% |
| Baxter International | 4 | 0 | 1 | 0 | €33.10 | €46.00 | 38.979% |
| GSK plc ADR | 6 | 0 | 1 | 0 | €36.00 | €49.33 | 37.020% |
| Sanofi S.A. ADR | 11 | 0 | 2 | 0 | €48.00 | €55.25 | 15.113% |
| Boston Scientific | 57 | 0 | 10 | 0 | €68.50 | €76.43 | 11.574% |
| Exact Sciences | 15 | 0 | 1 | 0 | €47.58 | €77.33 | 62.543% |
| Incyte Corp. | 14 | 2 | 2 | 1 | €60.14 | €78.05 | 29.775% |
| Henry Schein Inc. | 14 | 1 | 1 | 0 | €66.46 | €80.03 | 20.411% |
| Centene Corp. | 23 | 0 | 6 | 0 | €71.09 | €82.28 | 15.747% |
| Hologic Inc. | 20 | 0 | 3 | 0 | €75.50 | €83.99 | 11.250% |
| Edwards Lifesciences Corp. | 33 | 1 | 8 | 0 | €58.60 | €84.34 | 43.918% |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | €70.27 | €85.27 | 21.352% |